Biomet bribery probe may stall Zimmer Merger

Biomet Bribery Probe Looms Over Zimmer Merger (Medical Device Online)
The U.S. Department of Justice (DOJ) and the Securities and Exchange Commission (SEC) are reportedly conducting a probe into bribes allegedly made by Biomet Inc. to health providers in Brazil and customs officials in Mexico. The investigation is unlikely to stop the proposed merger between Biomet and Zimmer Holdings Inc., but Biomet could face stiff penalties.
According to confidential documents obtained by the New York Times, an anonymous email from a whistleblower sent in October 2013 tipped Biomet's officials that its loc...